EcoPhage has received another research and development grant from the Israeli Innovation Authority (IIA)
EcoPhage announces today that it has received another research and development grant from the Israeli Innovation Authority (IIA)
The Israel Innovation Authority, an independent publicly funded agency, was created to provide a variety of practical tools and funding platforms aimed at effectively addressing the dynamic and changing needs of the local and international innovation ecosystems. This includes early-stage entrepreneurs, mature companies developing new products or manufacturing processes, academic groups seeking to transfer their ideas to the market, global corporations interested in collaborating with Israeli technology, Israeli companies seeking new markets abroad and traditional factories and plants seeking to incorporate innovative and advanced manufacturing into their businesses.
EcoPhage received the grant to support one of its R&D projects to develop and commercialize bacteriophage-based solution including expanding its human resource, production and other activities needed to develop and commercialize the product.
“Being able to receive non-dilutive funds helps us in progressing with our plans”, said Guy Elitzur, EcoPhage’s CEO, “it positioned us in a better spot to bring more products and solution in the global area and start commercialization earlier than we thought”.
About EcoPhage
Ecophage pioneers the development and commercialization of bacteriophages-based bactericides with minimal environmental impact and maximum efficacy, addressing a crucial issue in global agriculture. Annually, an estimated 10% of the world’s food production is lost due to plant diseases, with bacterial infections being a significant contributor. Our innovative products harness the power of bacteriophages—viruses uniquely targeting bacteria—to prevent and cure plants, offering nontoxic solutions for bacterial diseases.
Our vision is clear – transformation of the global bactericides market in agriculture into more sustainable and safer to human, living and the environment.
We are doing that by setting up the mission of revolutionizing agriculture by increasing plant yield, reducing disease-related losses, and promoting sustainability. The foundation of our success lies in a proprietary technological platform co-developed with the prestigious Weizmann Institute of Science. Unlike conventional pesticides that often cause environmental harm and exhibit low efficacy, our bactericides represent a natural solution with minimal negative impact, high specificity, and superior effectiveness.
At Ecophage, we are not just combating plant diseases; we are transforming the future of agriculture, one innovative solution at a time.
For more information, contact : info@ecophage.com